Celcuity Inc. (CELC) stock
CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$64.17−0.15 (-0.23%)
Close on Nov 12, 2026Market cap $3.14BP/E –Yield –
Celcuity total assets
Total assets on the balance sheet at the end of each period.
Celcuity's total assets was $726.87M at Sep 30, 2026. For fiscal 2025 it was $466.56M, up 90.3% from the year before. The highest annual figure on record is $466.56M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $466.56M | +90.3% |
| FY2024 | Dec 31, 2024 | $245.12M | +28.2% |
| FY2023 | Dec 31, 2023 | $191.22M | +8.8% |
| FY2022 | Dec 31, 2022 | $175.70M | +104.5% |
| FY2021 | Dec 31, 2021 | $85.91M | +563.0% |
| FY2020 | Dec 31, 2020 | $12.96M | -36.1% |
| FY2019 | Dec 31, 2019 | $20.28M | -22.1% |
| FY2018 | Dec 31, 2018 | $26.03M | -18.6% |
| FY2017 | Dec 31, 2017 | $31.97M | +427.8% |
| FY2016 | Dec 31, 2016 | $6.06M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $726.87M | +52.7% |
| Q2 FY2026 | Jun 30, 2026 | $828.22M | +351.1% |
| Q1 FY2026 | Mar 31, 2026 | $410.16M | +88.0% |
| Q4 FY2025 | Dec 31, 2025 | $466.56M | +90.3% |
| Q3 FY2025 | Sep 30, 2025 | $476.00M | +74.3% |
| Q2 FY2025 | Jun 30, 2025 | $183.59M | -37.2% |
| Q1 FY2025 | Mar 31, 2025 | $218.13M | +15.9% |
| Q4 FY2024 | Dec 31, 2024 | $245.12M | +28.2% |
| Q3 FY2024 | Sep 30, 2024 | $273.04M | +91.8% |
| Q2 FY2024 | Jun 30, 2024 | $292.54M | +90.6% |
| Q1 FY2024 | Mar 31, 2024 | $188.18M | +14.1% |
| Q4 FY2023 | Dec 31, 2023 | $191.22M | +8.8% |
| Q3 FY2023 | Sep 30, 2023 | $142.38M | +118.1% |
| Q2 FY2023 | Jun 30, 2023 | $153.52M | +112.2% |
| Q1 FY2023 | Mar 31, 2023 | $164.87M | +106.3% |
| Q4 FY2022 | Dec 31, 2022 | $175.70M | +104.5% |
| Q3 FY2022 | Sep 30, 2022 | $65.29M | -28.9% |
| Q2 FY2022 | Jun 30, 2022 | $72.35M | +69.0% |
| Q1 FY2022 | Mar 31, 2022 | $79.93M | +119.8% |
| Q4 FY2021 | Dec 31, 2021 | $85.91M | +563.0% |
| Q3 FY2021 | Sep 30, 2021 | $91.84M | +515.8% |
| Q2 FY2021 | Jun 30, 2021 | $42.81M | +156.3% |
| Q1 FY2021 | Mar 31, 2021 | $36.37M | +97.7% |
| Q4 FY2020 | Dec 31, 2020 | $12.96M | -36.1% |
| Q3 FY2020 | Sep 30, 2020 | $14.91M | -31.4% |
| Q2 FY2020 | Jun 30, 2020 | $16.70M | -28.8% |
| Q1 FY2020 | Mar 31, 2020 | $18.39M | -26.3% |
| Q4 FY2019 | Dec 31, 2019 | $20.28M | -22.1% |
| Q3 FY2019 | Sep 30, 2019 | $21.74M | -22.1% |
| Q2 FY2019 | Jun 30, 2019 | $23.44M | -20.5% |
| Q1 FY2019 | Mar 31, 2019 | $24.94M | -18.8% |
| Q4 FY2018 | Dec 31, 2018 | $26.03M | -18.6% |
| Q3 FY2018 | Sep 30, 2018 | $27.89M | -15.8% |
| Q2 FY2018 | Jun 30, 2018 | $29.47M | +386.5% |
| Q1 FY2018 | Mar 31, 2018 | $30.73M | – |
| Q4 FY2017 | Dec 31, 2017 | $31.97M | – |
| Q3 FY2017 | Sep 30, 2017 | $33.15M | – |
| Q4 FY2016 | Dec 31, 2016 | $6.06M | – |
See a number that looks wrong?